These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Assessment of IL-31 levels and disease severity in children with atopic dermatitis. Ozceker D, Bulut M, Ozbay AC, Dilek F, Koser M, Tamay Z, Guler N. Allergol Immunopathol (Madr); 2018 Mar 24; 46(4):322-325. PubMed ID: 29555105 [Abstract] [Full Text] [Related]
12. The objective severity assessment of atopic dermatitis (OSAAD) score: validity, reliability and sensitivity in adult patients with atopic dermatitis. Angelova-Fischer I, Bauer A, Hipler UC, Petrov I, Kazandjieva J, Bruckner T, Diepgen T, Tsankov N, Williams M, Fischer TW, Elsner P, Fluhr JW. Br J Dermatol; 2005 Oct 24; 153(4):767-73. PubMed ID: 16181458 [Abstract] [Full Text] [Related]
13. Circulating interleukin 16 (IL-16) in children with atopic/eczema dermatitis syndrome (AEDS): a novel serological marker of disease activity. Frezzolini A, Paradisi M, Zaffiro A, Provini A, Cadoni S, Ruffelli M, De Pità O. Allergy; 2002 Sep 24; 57(9):815-20. PubMed ID: 12169178 [Abstract] [Full Text] [Related]
14. Expression levels of transcription factor PU.1 and interleukin-9 in atopic dermatitis and their relation to disease severity and eruption types. Hamza AM, Omar SS, Abo El-Wafa RA, Elatrash MJ. Int J Dermatol; 2017 May 24; 56(5):534-539. PubMed ID: 28229452 [Abstract] [Full Text] [Related]
15. Serum Fractalkine (CX3CL1) Concentration Correlates with Clinical Severity in Pediatric Atopic Dermatitis Patients. Chong S, Lan H, Zeng K, Zhao X. Ann Clin Lab Sci; 2016 May 24; 46(2):168-73. PubMed ID: 27098623 [Abstract] [Full Text] [Related]
16. Serum concentration of IL-18 correlates with disease extent in young children with atopic dermatitis. Hon KL, Leung TF, Ma KC, Wong CK, Wan H, Lam CW. Pediatr Dermatol; 2004 May 24; 21(6):619-22. PubMed ID: 15575842 [Abstract] [Full Text] [Related]